Nonsurgical treatment options for basal cell carcinoma

被引：1
作者：
Rao, Himanshu [1 ]
Cartron, Alexander [2 ]
Khachemoune, Amor [3 ,4 ]
机构：
[1] New York Inst Technol, Coll Osteopath Med, Glen Head, NY 11545 USA
[2] Maryland Mercy Med Ctr, Baltimore, MD USA
[3] Vet Affairs Med Ctr, Brooklyn, NY USA
[4] SUNY Downstates, Dept Dermatol, Brooklyn, NY USA
来源：
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2022年 / 35卷 / 11期
关键词：
basal cell; carcinoma; nonsurgical; treatment; skin cancer; superficial; PHOTODYNAMIC THERAPY; TOPICAL IMIQUIMOD; SKIN-CANCER; CRYOSURGERY; CURETTAGE; FLUOROURACIL;
D O I：
10.1097/01.JAA.0000885180.48906.6d
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Basal cell carcinoma (BCC) is the most common form of nonmelanoma skin cancer. Surgery, including Mobs micrographic surgery, is considered the gold standard for the management of BCC, yet some patients may be unable to undergo surgery. This article describes effective nonsurgical options for treating superficial BCCs as well as some nodular and infiltrative BCCs.
引用
收藏
页码：38 / 43
页数：6
相关论文
共 47 条
  • [1] Keratinocyte carcinoma
    Albert, MR
    Weinstock, MA
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2003, 53 (05) : 292 - 302
  • [2] American Academy of Dermatology, WHAT IS MOHS SURG
  • [3] American College of Mohs Surgery, SYMPT DIAGN
  • [4] Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial
    Arits, Aimee H. M. M.
    Mosterd, Klara
    Essers, Brigitte A. B.
    Spoorenberg, Eefje
    Sommer, Anja
    De Rooij, Michette J. M.
    van Pelt, Han P. A.
    Quaedvlieg, Patricia J. F.
    Krekels, Gertruud A. M.
    van Neer, Pierre A. F. A.
    Rijzewijk, Joris J.
    van Geest, Adrienne J.
    Steijlen, Peter M.
    Nelemans, Patty J.
    Kelleners-Smeets, Nicole W. J.
    [J]. LANCET ONCOLOGY, 2013, 14 (07) : 647 - 654
  • [5] Australasian College of Dermatologists, A Z SKIN BAS CELL CA
  • [6] Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial
    Basset-Seguin, N.
    Hauschild, A.
    Kunstfeld, R.
    Grob, J.
    Dreno, B.
    Mortier, L.
    Ascierto, P. A.
    Licitra, L.
    Dutriaux, C.
    Thomas, L.
    Meyer, N.
    Guillot, B.
    Dummer, R.
    Arenberger, P.
    Fife, K.
    Raimundo, A.
    Dika, E.
    Dimier, N.
    Fittipaldo, A.
    Xynos, I.
    Hansson, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 86 : 334 - 348
  • [7] Consensus recommendations for the treatment of basal cell carcinomas in Gorlin syndrome with topical methylaminolaevulinate- photodynamic therapy
    Basset-Seguin, N.
    Bissonnette, R.
    Girard, C.
    Haedersdal, M.
    Lear, J. T.
    Paul, C.
    Piaserico, S.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (05) : 626 - 632
  • [8] Brankov N, 2016, J CUTAN PATHOL, V43, P1139, DOI 10.1111/cup.12819
  • [9] Utility of radiotherapy for treatment of basal cell carcinoma: a review
    Cho, M.
    Gordon, L.
    Rembielak, A.
    Woo, T. C. S.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (05) : 968 - 973
  • [10] Basal Cell Carcinoma
    Chung, Seum
    [J]. ARCHIVES OF PLASTIC SURGERY-APS, 2012, 39 (02): : 166 - 170
12345